Literature DB >> 7927730

Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D.

J Y Chen1, Y Qiao, J L Komisar, W B Baze, I C Hsu, J Tseng.   

Abstract

Mice (BALB/cJ, C3H/HeN, and C3H/HeJ) primed with actinomycin D became highly susceptible to lethal intoxication with staphylococcal enterotoxin B (SEB). The mice underwent toxicosis and toxic shock and died. Actinomycin D-primed C3H/HeN and C3H/HeJ mice showed equal sensitivity to SEB, suggesting that bacterial lipopolysaccharide derived from gram-negative bacteria in the gut may not be an important cofactor in intoxication. In a time course study of the illness, prominent pathological changes characterized by blood congestion and thickening of alveolar septa were seen in the lung, while blood congestion, inflammation, epithelial cell flattening, and villous blunting were seen in the small intestine. In lymphoid tissues, such as the spleen, congestion, inflammation, and lymphoid cell depletion were the major reactions. The pathological features of the mice had many similarities to those of rhesus monkeys intoxicated with intravenous SEB. The actinomycin D-primed C3H/HeJ mice are thus an ideal mouse model for studying SEB toxicosis and toxic shock.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927730      PMCID: PMC303153          DOI: 10.1128/iai.62.10.4626-4631.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Difference in B cell mitogen responsiveness between closely related strains of mice.

Authors:  D L Rosenstreich; L M Glode
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  The genetic mapping of a defective LPS response gene in C3H/HeJ mice.

Authors:  J Watson; K Kelly; M Largen; B A Taylor
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Purification of staphylococcal enterotoxin B.

Authors:  E J Schantz; W G Roessler; J Wagman; L Spero; D A Dunnery; M S Bergdoll
Journal:  Biochemistry       Date:  1965-06       Impact factor: 3.162

4.  Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS.

Authors:  P M Schlievert
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

5.  Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B.

Authors:  G W Pettit; M R Elwell; P B Jahrling
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

6.  Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after intravenous administration to monkeys.

Authors:  W R Beisel
Journal:  Toxicon       Date:  1972-08       Impact factor: 3.033

Review 7.  Toxic shock syndrome: a review.

Authors:  S W Wright; A T Trott
Journal:  Ann Emerg Med       Date:  1988-03       Impact factor: 5.721

8.  Effect of enterotoxin B on human volunteers.

Authors:  H D Raj; M S Bergdoll
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

9.  Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.

Authors:  D J Fast; P M Schlievert; R D Nelson
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen.

Authors:  M Bette; M K Schäfer; N van Rooijen; E Weihe; B Fleischer
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.

Authors:  G H Lowell; C Colleton; D Frost; R W Kaminski; M Hughes; J Hatch; C Hooper; J Estep; L Pitt; M Topper; R E Hunt; W Baker; W B Baze
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Authors:  Yuanyuan Liu; Zhen Song; Shuang Ge; Jinyong Zhang; Limin Xu; Feng Yang; Dongshui Lu; Ping Luo; Jiang Gu; Quanming Zou; Hao Zeng
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

4.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology.

Authors:  Sarah J C Whitfield; Chris Taylor; Jane E Risdall; Gareth D Griffiths; James T A Jones; E Diane Williamson; Sjoerd Rijpkema; Luisa Saraiva; Sandrine Vessillier; A Christopher Green; Alun J Carter
Journal:  J Immunol       Date:  2017-03-20       Impact factor: 5.422

6.  Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1.

Authors:  B G Stiles; Y G Campbell; R M Castle; S A Grove
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Resilience to bacterial infection: difference between species could be due to proteins in serum.

Authors:  H Shaw Warren; Catherine Fitting; Eva Hoff; Minou Adib-Conquy; Laura Beasley-Topliffe; Brenda Tesini; Xueya Liang; Catherine Valentine; Judith Hellman; Douglas Hayden; Jean-Marc Cavaillon
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Proinflammatory mediators of toxic shock and their correlation to lethality.

Authors:  Teresa Krakauer; Marilyn J Buckley; Diana Fisher
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

9.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Intranasal rapamycin rescues mice from staphylococcal enterotoxin B-induced shock.

Authors:  Teresa Krakauer; Marilyn Buckley
Journal:  Toxins (Basel)       Date:  2012-09-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.